Quetiapine
| Quetiapine | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 383.5 g/mol [1] |
| Appearance | Solid [1] |
| Melting point | 174-176 [1] |
| Boiling point | 556.5±60.0 [1] |
| Solubility | 49.4 [ug/mL] (The mean of the results at pH 7.4) [1] |
| Predicted LogP | 2.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C21H25N3O2S [1] |
| IUPAC name | 2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol [1] |
| SMILES | C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42 [1] |
| InChI | InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2 [1] |
| InChIKey | URKOMYMAXPYINW-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 7 hours (parent compound); 9 – 12 hours (active metabolite, norquetiapine)Truven Health Analytics, Inc. DrugPoint System (Internet) [cited 2013 Sep 18]. Greenwood Village, CO: Thomsen Healthcare; 2013. |
| Dosing[] |
|---|
| Oral [] | |
|---|---|
| Light | ≤ 25 mg(33x - 68.8%) |
| Common | 25 mg |
| Strong | 25 - 50 mg(9x - 18.8%) |
| Heavy | 50 - 115 mg(1x - 2.1%) |
| Extreme | 115 mg +(5x - 10.4%) |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Quetiapine (also known as quetiapina, Norsic, quetiapinum, 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol, Quetiapine extended release, NSC-758918, 2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol, Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-, CHEBI:8707 or Dtxcid903546) is a
Chemistry
Stereochemistry []
Quetiapine is a achiral mixture.
Pharmacology
ATC Classification
In the nervous system (N) quetiapine acts as a antipsychotic (N05A), diazepines, oxazepines, thiazepines and oxepine (N05AH), psycholeptic (N05) and quetiapine (N05AH04).[1]Interactions []
| CYP3A4 | induction / inhibition |
|---|
Subjective effects []
| magnus / Quetiapine [] | |
|---|---|
Routes:
| |
| bonzi / Quetiapine [] | |
|---|---|
| Pilz / Quetiapine [] | |
|---|---|
Routes:
| |
| 0xea / Quetiapine [] | |
|---|---|
Routes:
| |
Experience reports
Erowid
There are currently 26 experience reports involving quetiapine on Erowid: []
- "No Go" by Narr
- "The Dysphoria Drug" by Plutonium Boss
- "Less Anxious and More Relaxed" by ChiaPetOG
- "Mild Hallucinations and Disorientation" by Anonymous
- "So Far So Good" by MDW
- "How I Got My Life Back" by Guani
- "Suicide Prevention" by Xdefeatsy
- "Sleepy Nights and Mornings" by Stretch
- "Effect of 'Atypical' Psychotropic with Meth" by Gengis Kaine
- "Appreciating the Benefits" by Mike
- "Recreation?" by Lotus Blossom
- "Treats Withdrawal" by Durandal
- "I Would Never Take It Again" by selected
- "Cool Visuals" by WatersMoon110
- "Peeking Into the Abyss of a Cure" by EvanesEmperor
- "Beware of Seroquel with Weed" by SaySho
- "D.O.C. of Institutions" by Bow
- "I Was Short of Breath" by syrossoul
- "For Opiate Wthdrawals" by Danyv
- "Poor Luck with Newer Atypical Antipsychotic" by far2farside8
- "Worked for a While" by far2farside8
- "Nightly Vivid Dreams" by Dmanic
- "Its Great if Used Responsibly" by Herr Mannelig
- "Zombie Life Saver" by bugman
- "Works Well as a Sleep-Aid" by Gigaza
- "To Solve a Bad Trip" by Max_AvA
Legal status []
- Australia: Quetiapine is a S4 substance.[3]
- Brazil: Quetiapine is a C1 substance.
- Canada: Quetiapine is a prescription only substance.
- New Zealand: Quetiapine is a Prescription only substance.
- United Kingdom: Quetiapine is a prescription only substance.
- United States: Quetiapine is a prescription only substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5002, quetiapine. Accessed May 17, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5002
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Quetiapine. UNII: BGL0JSY5SI. Global Substance Registration System. Accessed May 17, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/BGL0JSY5SI
Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017. June 21, 2022. Accessed May 17, 2026. https://www.tga.gov.au/resources/publication/publications/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines-2017